Global Markets for Specialty Surgical Wound Care Products: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products
111 Pages |
52 Exhibits |
Order individually or subscribe to Medtech Pro and get a complete intel platform.
Overview
The global market for specialty surgical wound care products-which include sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.1 billion in 2012. Growth is being largely driven by the markets of Asia-Pacific and the Rest-of-the-World, where greater product availability, new indications, and underlying market dynamics-such as rising surgical procedure volumes-are helping to offset sluggishness in the U.S. market. While global revenues are expected to reach $4.2 billion in 2018, key trends, such as efforts to limit expensive hospital admissions, shift procedures to outpatient settings, and reduce rates of readmissions, will have decisive effects on the market for these technologies.
Critical Issues Covered in this Report:
•Analysis of the clinical status of key technologies as well as potential new indications and product introductions;
•The competitive landscape for these products in the U.S. and international markets; and
•Market quantities, including procedure volumes, units, revenues per procedure, and detailed segmentation among product categories.
Companies Covered
Baxter InternationalCovidien
CryoLife
CSL Behring
Davol (C.R. Bard)
Ethicon (Johnson & Johnson)
Genzyme (Sanofi-Aventis)
HemCon Medical Technologies
Hyperbranch Medical Technology
King Pharmaceuticals (Pfizer)
MAST Biosurgery
Medafor
Neomend
Orthovita (Stryker)
Pfizer
Takeda Pharmaceuticals International
Tenaxis Medical
ThermoGenesis
Tissuemed
Vivostat A/S
Zymogenetics (Bristol-Myers Squibb)
Table of Contents
1. EXECUTIVE SUMMARY 1.1 The U.S. Market for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products 1.2 The European Market for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products 1.3 The Market for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products in AP & ROW Countries 1.4 Global Supplier Shares Exhibit 1-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type Exhibit 1-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Region Exhibit 1-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type Exhibit 1-4: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type Exhibit 1-5: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type Exhibit 1-6: Global Supplier Shares in 2011 and 2012 2. OVERVIEW 2.1 The Wound Healing Process 2.1.1 The Inflammatory Phase 2.1.2 Proliferative Phase 2.1.3 Remodeling Phase 2.2 Types of Wound Healing 2.3 Products 2.3.1 Sutures 2.3.2 Staples 2.3.3 Tapes 2.3.4 Surgical Adhesives Exhibit 2-1: The Three Stages of the Wound Healing Process Exhibit 2-2: Types of Wound Healing Exhibit 2-3: Types of Products Used in Wound Closure 3. SURGICAL SEALANTS, GLUES, ABSORBABLE HEMOSTATS, & ADHESION PREVENTION PRODUCTS 3.1 Indications 3.2 Product Types 3.2.1 Sealants 3.2.2 Glues 3.2.3 Absorbable Hemostats 3.2.4 Adhesion Prevention Products 3.3 Companies and Products Exhibit 3-1: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products Exhibit 3-2: Leading Indications for Surgical Wound Closure Products Exhibit 3-3: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products in 2013 4. PROCEDURES & MARKET FORECASTS: SURGICAL SEALANTS, GLUES, ABSORBABLE HEMOSTATS, & ADHESION PREVENTION PRODUCTS 4.1 The United States: Procedures & Market Forecasts 4.1.1 Surgical Sealants in the U.S.: Procedures & Market Forecasts 4.1.2 Surgical Glues in the U.S.: Procedures & Market Forecasts 4.1.3 Absorbable Hemostats in the U.S.: Procedures & Market Forecasts 4.1.4 Adhesion Prevention Products in the U.S.: Procedures & Market Forecasts 4.1.5 Supplier Shares 4.2 Europe: Procedures & Market Forecasts 4.2.1 Surgical Sealants in Europe: Procedures & Market Forecasts 4.2.2 Surgical Glues in Europe: Procedures & Market Forecasts 4.2.3 Absorbable Hemostats in Europe: Procedures & Market Forecasts 4.2.4 Adhesion Prevention Products in Europe: Procedures & Market Forecasts 4.3 Asia-Pacific & the Rest-of-the-World: Procedures & Market Forecasts 4.3.1 Surgical Sealants in AP & ROW Countries: Procedures & Market Forecasts 4.3.2 Surgical Glues in AP & ROW Countries: Procedures & Market Forecasts 4.3.3 Absorbable Hemostats in AP & ROW Countries: Procedures & Market Forecasts 4.3.4 Adhesion Prevention Products in AP & ROW Countries: Procedures & Market Forecasts 4.4 OUS Supplier Shares Exhibit 4-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type Exhibit 4-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Region Exhibit 4-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type Exhibit 4-4: Targeted Surgical Caseloads in the U.S. from 2011-2018 Exhibit 4-5: Factors Influencing the U.S. Market for Surgical Sealants Exhibit 4-6: The U.S. Market Forecast for Surgical Sealants from 2011-2018 Exhibit 4-7: The U.S. Market Forecast for External and Internal Tissue Sealants from 2011-2018 Exhibit 4-8: Factors Influencing the U.S. Market for Surgical Glues Exhibit 4-9: The U.S. Market Forecast for Surgical Glues from 2011-2018 Exhibit 4-10: The U.S. Market Forecast for Surgical Glues, Approved & Off-Label Uses, from 2011-2018 Exhibit 4-11: Factors Influencing the U.S. Market for Absorbable Hemostats Exhibit 4-12: The U.S. Market Forecast for Absorbable Hemostats from 2011-2018 Exhibit 4-13: Factors Influencing the U.S. Market for Adhesion Prevention Products Exhibit 4-14: The U.S. Market Forecast for Adhesion Prevention Products from 2011-2018 Exhibit 4-15: U.S. Supplier Shares in 2011 and 2012 Exhibit 4-16: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type Exhibit 4-17: Targeted Surgical Caseloads in Europe from 2011-2018 Exhibit 4-18: Factors Influencing the European Market for Surgical Sealants Exhibit 4-19: The European Market Forecast for Surgical Sealants from 2011-2018 Exhibit 4-20: The European Market Forecast for External and Internal Tissue Sealants from 2011-2018 Exhibit 4-21: Factors Influencing the European Market for Surgical Glues Exhibit 4-22: The European Market Forecast for Surgical Glues from 2011-2018 Exhibit 4-23: The European Market Forecast for Surgical Glues from 2011-2018: Open Repairs of the Large Vessels & Other Indications Exhibit 4-24: Factors Influencing the European Market for Absorbable Hemostats Exhibit 4-25: The European Market Forecast for Absorbable Hemostats from 2011-2018 Exhibit 4-26: Factors Influencing the European Market for Adhesion Prevention Products Exhibit 4-27: The European Market Forecast for Adhesion Prevention Products from 2011-2018 Exhibit 4-28: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type Exhibit 4-29: Targeted Surgical Caseloads in AP & ROW Countries from 2011-2018 Exhibit 4-30: Factors Influencing the Market for Surgical Sealants in AP & ROW Countries Exhibit 4-31: The AP & ROW Market Forecast for Surgical Sealants from 2011-2018 Exhibit 4-32: The AP & ROW Market Forecast for External and Internal Tissue Sealants from 2011-2018 Exhibit 4-33: Factors Influencing the Market for Surgical Glues in AP & ROW Countries Exhibit 4-34: The AP & ROW Market Forecast for Surgical Glues from 2011-2018 Exhibit 4-35: The AP & ROW Market Forecast for Surgical Glues from 2011-2018: Open Repairs of the Large Vessels & Other Indications Exhibit 4-36: Factors Influencing the Market for Absorbable Hemostats in AP & ROW Countries Exhibit 4-37: The AP & ROW Market Forecast for Absorbable Hemostats from 2011-2018 Exhibit 4-38: Factors Influencing the Market for Adhesion Prevention Products in AP & ROW Countries Exhibit 4-39: The AP & ROW Market Forecast for Adhesion Prevention Products from 2011-2018 Exhibit 4-40: OUS Supplier Shares in 2011 and 2012 5. COMPANY PROFILES 5.1 Baxter International 5.2 Covidien 5.3 CryoLife 5.4 CSL Behring 5.5 Davol (C.R. Bard) 5.6 Ethicon (Johnson & Johnson) 5.7 Genzyme (Sanofi-Aventis) 5.8 Pfizer 5.9 Takeda Pharmaceuticals International 5.10 Zymogenetics (Bristol-Myers Squibb)
